The burgeoning field ofinvestigations into novel anxiolytics is rapidly expanding, with novel research chemicals showing favorable results in preclinical and clinical studies. These here molecules often exhibit distinct mechanisms of action compared to traditional anti-anxiety medications, offering potential advantages for subjects struggling with